Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1Hypocalcemia 1Hyperparathyroidism, Secondary 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

Ibandronic Acid 5Zoledronic Acid 3Denosumab 3pembrolizumab 2Sunitinib 2Radiotherapy, Intensity-Modulated 2Nivolumab 2Methods 2Interviews as Topic 2Injections 2Curettage 2selinexor 1saracatinib 1ridaforolimus 1radium Ra 223 dichloride 1pegfilgrastim 1olaparib 1montanide ISA 51 1lentiviral minigene vaccine of COVID-19 coronavirus 1endostar protein 1cc-486 1angiotensin I (1-7) 1Vincristine 1Transplantation, Homologous 1Transplantation, Autologous 1Transcranial Direct Current Stimulation 1Trabectedin 1Tomography, Spiral Computed 1TES 1Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Bone Neoplasms × Calcifediol × Clear all
NCT02274623 2019-09-27

Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid

OPKO Health, Inc.

Phase 1 Completed
33 enrolled
BreastGenitourinaryHead & NeckSarcoma

Bone Neoplasms, Breast Neoplasms, Hyperparathyroidism, Secondary, Hypocalcemia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡